Idiopathic anaphylaxis successfully treated with omalizumab

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 5, 2008, Pages 550-551

  Jones, Jeremy D ^a   Marney Jr , Samuel R ^a   Fahrenholz, John M ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; 5 HYDROXYINDOLEACETIC ACID; ADRENALIN; ANTIHISTAMINIC AGENT; BENZOIC ACID; CATECHOLAMINE; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB; SODIUM METABISULFITE;

ABDOMINAL CRAMP; ADULT; ALLERGIC RHINITIS; ANAPHYLAXIS; BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CHRONIC SINUSITIS; DIARRHEA; DISEASE SEVERITY; DYSPNEA; EXERCISE; FLUSHING; HEART PALPITATION; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; HYPOTENSION; IDIOPATHIC DISEASE; LETTER; MALE; MAST CELL; MORBIDITY; PRIORITY JOURNAL; PROVOCATION TEST; RADIOALLERGOSORBENT TEST; RECURRENT DISEASE; SINUSITIS; URTICARIA PIGMENTOSA;

EID: 55849096553     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60296-7     Document Type: Letter

References (8)

1. Leynadier F, Doudou O, Gaouar H, et al. Effect of omalizumab in health care workers with occupational latex allergy. J Allergy Clin Immunol. 2004;113:360-361.
2. Sampson HA. A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of XOLAIR (omalizumab) in peanut allergy (TOPS). J Allergy Clin Immunol. 2007;119(suppl 1):S117.
3. Shapiro CA, Kapetanos NS, Sarmiento E. Successful treatment of chronic idiopathic urticaria and angioedema (CIU), with Xolair (omalizumab). J Allergy Clin Immunol. 2007;119(suppl 1):S274.
4. Rafi A, Do L, Mangat R, Sender S, Katz RM. Efficacy of omalizumab for the treatment of allergic urticaria and angioedema. J Allergy Clin Immunol. 2007;119(suppl 1):S312.
5. Majmundar A, Khan D. Successful therapy with omalizumab for imported fire ant anaphylaxis. J Allergy Clin Immunol. 2005;115(suppl 1):S38.
6. Bacal E, Patterson R, Zeiss CR. Evaluation of severe (anaphylactic) reactions. Clin Allergy. 1978;8:295-304.
7. Greenberger P. Idiopathic anaphylaxis. Immunol Allergy Clin N Am. 2007;27:273-293.
8. Chang TW, Shiung YY. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol. 2006;117:1203-1212.